HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9
HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9
HC Wainwright & Co.以买入评级开始报道ImmunoPrecise抗体,宣布目标价为9美元
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy rating and announces Price Target of $9.
HC Wainwright & Co. 分析师Swayampakula Ramakanth以买入评级开始对ImmunoPrecise Antives(纳斯达克股票代码:IPA)进行报道,并宣布目标价为9美元。